Article

Pyruvate Oxidation Sustains B Cell Antigen-Specific Activation to Exacerbate MASH

medRxiv · 2023 · Barrow, F.; Wang, H.; Fredrickson, G.; Florczak, K.; Ciske, E.; Khanal, S.; Parthiban, P.; Nguyen, H.; Rios, E.; Kostallari, E.; Revelo, X.

Key facts

Title Pyruvate Oxidation Sustains B Cell Antigen-Specific Activation to Exacerbate MASH
First author Barrow, F.; Wang, H.; Fredrickson, G.; Florczak, K.; Ciske, E.; Khanal, S.; Parthiban, P.; Nguyen, H.; Rios, E.; Kostallari, E.; Revelo, X.
Journal medRxiv
Published Nov 15, 2023
DOI 10.1101/2023.11.13.566832
Devices mentioned K073487, K073489, K073490, K925155, K973350, K990827
Product codes mentioned CFN, CIT, JJH, JLX, KQP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature